SCHEMBL19559715

SCHEMBL19559715

CCC1=CC=C(C(COc2ccc(CC3(C)SC(=O)N(N)C3=O)cc2)OC(=O)c2ccccc2)NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19217588 0.87 PPARG (0.32) —
SCHEMBL19559794 0.74 — —
SCHEMBL16491937 0.68 PPARG (0.45) —
SCHEMBL6931095 0.68 PPARG (0.45) —
SCHEMBL14213680 0.67 PPARG (0.41) —
SCHEMBL16489283 0.67 PPARG (0.41) —
SCHEMBL6928360 0.66 PPARG (0.36) —
SCHEMBL14213688 0.66 PPARG (0.33) —
SCHEMBL19559811 0.64 PPARG (0.52) —
SCHEMBL19559771 0.61 PPARG (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513070-B1 PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES CIRIUS THERAPEUTICS INC (US) 2017-11-08 — — EP disclosed
Send feedback